Aberdeen Group’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.33M Buy
401,624
+152,725
+61% +$3.17M 0.01% 638
2025
Q1
$4.31M Buy
248,899
+77,511
+45% +$1.34M 0.01% 694
2024
Q4
$4.65M Sell
171,388
-45,695
-21% -$1.24M 0.01% 661
2024
Q3
$9.53M Buy
217,083
+123,789
+133% +$5.43M 0.02% 530
2024
Q2
$3.66M Buy
+93,294
New +$3.66M 0.01% 682